Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

December 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

December 1, 2025

Conditions
OverweightObesity
Interventions
OTHER

Source document data collection

Data from all adult patients, of both sexes, for whom combination treatment with sibutramine and topiramate, both at any dose/dosage, were prescribed between the year 2011 and the beginning of the study will be colected in the study.

Trial Locations (2)

06696-000

Eurofarma Laboratórios S.A, São Paulo

Unknown

HC-FMUSP, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY